0 190

Cited 0 times in

B-acute lymphoblastic leukemia/lymphoma (B-ALL) with precedent or concurrent myelodysplastic syndrome (MDS) with deletion 5q

Authors
 Jin Woo Joo  ;  Sergej Konoplev  ;  Timothy J. McDonnell  ;  Chi Young Ok 
Citation
 JOURNAL OF HEMATOPATHOLOGY, Vol.10 : 75-80, 2017-08 
Journal Title
JOURNAL OF HEMATOPATHOLOGY
ISSN
 1868-9256 
Issue Date
2017-08
Keywords
MDS ; B-all ; Del (5q)
Abstract
Progression to acute leukemia is an inherited feature of myelodysplastic syndrome (MDS). While majority of acute leukemia cases in this setting is acute myeloid leukemia (AML), rare cases of acute B-lymphoblastic leukemia/lymphoma (B-ALL) also exist. Therefore, detection of increased blasts in a patient with MDS should not be equated with a diagnosis of AML; full immunophenotyping of blasts is required. Previous reports indicate that dysplastic myeloid cells and B-lymphoblasts belong to the same clone. However, dysplastic myeloid cells and B-lymphoblasts could be clonally unrelated. Decitabine in addition to hyperCVAD (fractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone alternating with high-dose methotrexate and cytarabine) could be a good treatment option in this particular clinical setting.
Full Text
https://link.springer.com/article/10.1007/s12308-017-0298-7
DOI
10.1007/s12308-017-0298-7
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195770
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links